Skip to main content
Clinical Trials/JPRN-UMIN000009683
JPRN-UMIN000009683
Recruiting
未知

Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiationtherapy in patients with borderline resectable pancreatic head cancer - CMS deployment promises safe neoadjuvant chemoradiationtherapy in patients with borderline resectable pancreatic head cancer

Yokohama City University Endoscopic devision0 sites40 target enrollmentJanuary 3, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Pancreatic cancer
Sponsor
Yokohama City University Endoscopic devision
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 3, 2013
End Date
March 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yokohama City University Endoscopic devision

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Under the age of 19, non\-Borderline resectable pancreatic head cancer based on NCCN guideline 2012\.

Outcomes

Primary Outcomes

Not specified

Similar Trials